Deals
Pfizer CEO Faces U.K. Panel as Resistance to Bid Hardens
This article is for subscribers only.
Pfizer Inc. Chief Executive Officer Ian Read faces heightened public scrutiny of his bid for AstraZeneca Plc this week when he’ll be questioned by lawmakers on his commitment to the U.K. in hearings broadcast live.
Read has been summoned by separate parliamentary committees to testify on the U.S. company’s offer of about $106 billion for London-based AstraZeneca, the biggest takeover bid in U.K. history. He and AstraZeneca CEO Pascal Soriot are scheduled to appear before the Business, Innovation and Skills Committee tomorrow and the Science and Technology Committee on May 14.